drugset / Trial / NCT04186442
Evaluate the Safety and Efficacy of Botulax® Versus Botox® in Patient With Overactive Bladder
RandomizedParallel-groupDouble-blindTreatment
Summary
To determine the efficacy and safety of Botulax® in treatment of Overactive Bladder
Timeline
- Start
- 2020-05-12
- Primary completion
- 2021-04-26
- Completion
- 2021-10-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | — |